CPAP or BiPAP therapy compliance significantly improved survival in patients with left ventricular assist devices (LVADs) who had obstructive sleep apnea, according to a 15-year retrospective analysis. LVAD recipients with sleep apnea who consistently used positive airway pressure therapy showed markedly better long-term survival compared to non-compliant patients, though the study did not find survival differences between those with and without sleep apnea overall. This finding highlights a critical intersection between sleep medicine and advanced heart failure care that could reshape perioperative protocols. LVAD patients represent some of the most critically ill cardiac patients, often serving as bridges to heart transplantation or as permanent therapy. The survival benefit from CPAP compliance in this population suggests that sleep-disordered breathing may amplify cardiovascular stress even in patients already receiving mechanical circulatory support. However, this single-center retrospective study awaits peer review, and the observational design cannot establish causation. The researchers acknowledge that multicenter validation is essential before changing clinical practice guidelines. Given the relatively simple, low-risk nature of CPAP therapy, these preliminary findings suggest sleep apnea screening could become standard care for LVAD candidates, potentially improving outcomes in this vulnerable population.